Ovarian cancer often goes undetected for a long time. In seven out of 10 patients, the tumor has already formed secondary ...

Multimodality Therapy for Locally Advanced Cervical Carcinoma: State of the Art and Future Directions We reviewed the current evidence on the clinical management of these relatively rare ovarian ...

The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

High-risk MSCs (yellow) are more abundant in fallopian tubes from patients with STIC lesions (bottom) compared to those without these lesions (top). Researchers at the University of Pittsburgh have ...

Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer: a subset of progenitor cells that reside in fallopian tube supportive tissue, or stroma.

Melina Schuh has been fascinated with ovarian germ cells, or oocytes, since she began her graduate studies in 2004. “[I] realized that only little was known about these important cells that are ...

Most ovarian cancers are treated the same way regardless of stage: surgery followed by chemotherapy. Stromal tumors are treated with surgery followed by chemotherapy or hormone therapy. In most cases, ...

In a major scientific breakthrough, newly published research from an international consortium led by the University of Minnesota's Masonic Cancer Center has the potential to transform the landscape of ...

Stromal endometriosis is a term used to specify the nature of tissue present in endometriosis. A diagnosis featuring this type of cell could mean endometrial lesions are more challenging to spot ...